Oxymap is a company that develops medical devices and software for ophthalmology. Its technology enables ophthalmologists to evaluate the oxygen saturation in the retinal blood vessels. It allows metabolic and structural imaging of the retina and evaluation of the pathophysiology of common eye diseases such as retinal vascular occlusions, diabetic retinopathy, age-related macular degeneration, and glaucoma.